Raynaud phenomenon in three patients with acquired immune deficiency syndrome-related Kaposi sarcoma treated with bleomycin.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 7689922.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
The authors report three cases of Raynaud phenomenon that developed during doxorubicin, bleomycin, and vincristine (ABV) therapy for acquired immune deficiency syndrome (AIDS)-related Kaposi sarcoma. Although Raynaud phenomenon is well documented as a side effect of bleomycin, vinblastine, and cisplatin chemotherapy for germ cell neoplasms, it has not been widely documented in patients with AIDS.
Medical subject headings
- Acquired Immunodeficiency Syndrome
- Antineoplastic Combined Chemotherapy Protocols
- Bleomycin
- Raynaud Disease
- Sarcoma, Kaposi